StockData
Eledon Pharmaceuticals, Inc. logo

Eledon Pharmaceuticals, Inc. (ELDN) shareholders

ELDNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.98+0.01 (+0.51%)

Close on Nov 17, 2026Market cap $160.90MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
57.8%
47M of 81M shares
Institutional holders
161
51 new, 9 sold out
Net institutional buying
4M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Bvf Inc/Il
Joint filing with Bvf Partners L P/Il (9.99%), Lampert Mark N (9.99%) and 3 more
7,868,4199.99%13G (passive) amendmentMar 31, 2026
Matthew D. Perry
Joint filing with Coastlands Capital LP (5.28%), Coastlands Capital Partners LP (5.28%) and 2 more
4,762,6915.98%13G (passive)Nov 19, 2025
BlackRock, Inc.4,380,8575.80%13G (passive)Mar 31, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of ELDNValueChange% of portfolio
Bvf Inc/Il6,293,2827.74%$24.80M–0.63%
BlackRock, Inc.5,123,8426.31%$20.19M+741,5970.00%
Defilade Capital Management, L.P.3,525,3384.34%$13.89M−38,7891.86%
Vanguard Capital Management LLC3,417,2234.21%$13.46M+124,0890.00%
Goldman Sachs Group Inc2,510,3083.09%$9.89M+2,140,2180.00%
Ensign Peak Advisors, Inc2,101,2242.59%$8.28M−363,6950.01%
Geode Capital Management, LLC1,956,6012.41%$7.71M+164,8180.00%
Catalio Capital Management, LP1,695,0712.09%$6.68M+55,2551.26%
State Street Corp1,621,9692.00%$6.39M+467,2980.00%
Zimmer Partners, LP1,596,5991.96%$6.29M−278,4010.14%
Sphera Funds Management Ltd.1,191,1871.47%$4.69M−580,9440.61%
AWM Investment Company, Inc.1,100,0001.35%$4.33M–0.38%
UBS Group AG1,048,2451.29%$4.13M+500,7980.00%
Kingdon Capital Management, L.L.C.1,039,2751.28%$4.09M–0.42%
Millennium Management LLC979,7121.21%$3.86MNew0.00%
Bank Of America Corp /De/883,0971.09%$3.48M+13,5530.00%
ADAR1 Capital Management, LLC647,8120.80%$2.55M−326,6090.12%
22NW, LP636,3640.78%$2.51M–2.40%
Northern Trust Corp616,3990.76%$2.43M+72,5570.00%
Aqr Capital Management LLC581,0280.72%$2.29M+408,6110.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202616147M57.8%51 / 6222 / 910M5M
Q1 202612143M52.4%42 / 3520 / 158M6M
Q4 20259544M54.3%32 / 3217 / 1918M11M
Q3 20258336M44.9%21 / 2322 / 217M11M
Q2 20258541M50.3%28 / 2115 / 266M4M
Q1 20258338M47.3%18 / 1721 / 104M5M
Q4 20247538M47.4%45 / 192 / 323M3M
Q3 20243318M22.7%3 / 97 / 11M1M
Q2 20243219M23.2%7 / 142 / 49M0M
Q1 20242910M11.8%3 / 98 / 31M0M
Q4 2023299M11.3%5 / 87 / 31M0M
Q3 2023289M11.0%3 / 89 / 80M1M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

97 funds held ELDN in Q2 2026, 67% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of ELDNValue% of fundAs of
Vanguard Total Stock Market Index Fund2,483,1623.06%$9.78M0.00%Jun 30, 2026
iShares Russell 2000 ETF2,038,1602.51%$8.03M0.01%Jun 30, 2026
Vanguard Extended Market Index Fund854,6341.05%$3.37M0.00%Jun 30, 2026
Fidelity Small Cap Index Fund839,2051.03%$2.84M0.01%Jul 31, 2026
iShares Russell 2000 Growth ETF723,4070.89%$2.85M0.02%Jun 30, 2026
Fidelity Extended Market Index Fund389,3710.48%$1.48M0.00%May 31, 2026
Vanguard Russell 2000 Index Fund383,9830.47%$1.46M0.01%May 31, 2026
Goldman Sachs Small Cap Equity Insights Fund311,9930.38%$1.05M0.10%Jul 31, 2026
Goldman Sachs Small Cap Value Insights Fund286,0120.35%$966.72K0.07%Jul 31, 2026
iShares Micro-Cap ETF255,2330.31%$1.01M0.07%Jun 30, 2026
Dimensional U.S. Small Cap ETF196,8970.24%$665.51K0.00%Jul 31, 2026
Schwab Small-Cap Index Fund187,4170.23%$633.47K0.01%Jul 31, 2026
Fidelity Total Market Index Fund141,6490.17%$539.68K0.00%May 31, 2026
Master Small Cap Index Series134,9530.17%$531.71K0.01%Jun 30, 2026
Goldman Sachs Small Cap Growth Insights Fund129,5480.16%$437.87K0.13%Jul 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
David-Alexandre C. GrosChief Executive Officer, Director363,4540.45%Aug 4, 2026
Steven PerrinPresident, Director153,3530.19%Aug 4, 2026
Paul Sean LittleChief Financial Officer10,0000.01%Jan 13, 2025
Bryan E. SmithGeneral Counsel, Corporate Sec––Jan 13, 2025
Jan HillsonDirector3,4300.00%Jan 16, 2026
James A. Robinson Jr.Director3,4300.00%Jan 16, 2026
Allan KirkDirector3,4300.00%Jan 16, 2026
John S. McBrideDirector3,4300.00%Jan 16, 2026
Keith KatkinDirector8,5750.01%Jan 16, 2026
June LeeDirector3,4300.00%Jan 16, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
David-Alexandre C. Gros
Chief Executive Officer, Director
Jul 31, 2026Award+354,454––363,454
David-Alexandre C. Gros
Chief Executive Officer, Director
Jul 31, 2026Tax withholding−194,791$3.38$658.39K168,663
Steven Perrin
President, Director
Jul 31, 2026Award+152,353––153,353
Steven Perrin
President, Director
Jul 31, 2026Tax withholding−72,138$3.38$243.83K81,215
John S. McBride
Director
Jan 10, 2026Option exercise+3,430––3,430
Jan Hillson
Director
Jan 10, 2026Option exercise+3,430––3,430
James A. Robinson Jr.
Director
Jan 10, 2026Option exercise+3,430––3,430
June Lee
Director
Jan 10, 2026Option exercise+3,430––3,430
Allan Kirk
Director
Jan 10, 2026Option exercise+3,430––3,430
Keith Katkin
Director
Jan 10, 2026Option exercise+8,575––8,575
Inc/Il Bvf
10% owner
May 9, 2024Buy+75,431––220,460
Inc/Il Bvf
10% owner
May 9, 2024Buy+821,121––2,633,679
Inc/Il Bvf
10% owner
May 9, 2024Buy+1,031,385––3,361,803
Value Trading Fund OS LP Biotechnology
–
May 5, 2023Buy+1,055,445––2,330,418
Value Trading Fund OS LP Biotechnology
–
May 5, 2023Buy+86,341––145,029
Value Trading Fund OS LP Biotechnology
–
May 5, 2023Buy+837,146––1,812,558
Steven Perrin
President, Director
Nov 23, 2022Buy+1,000$2.60$2.60K1,000
David-Alexandre C. Gros
Chief Executive Officer, Director
Dec 20, 2021Buy+2,000$4.48$8.96K9,000
David-Alexandre C. Gros
Chief Executive Officer, Director
Aug 17, 2021Buy+4,000$6.21$24.84K7,000
Paul Sean Little
CHIEF FINANCIAL OFFICER
Jun 11, 2021Buy+10,000$8.87$88.70K10,000
David-Alexandre C. Gros
Chief Executive Officer, Director
Jun 9, 2021Buy+3,000$8.01$24.03K3,000
Mark N. Lampert
–
Dec 22, 2020Conversion+11,278––89,214
Mark N. Lampert
–
Dec 22, 2020Conversion+15,166––117,565
Mark N. Lampert
–
Dec 22, 2020Conversion+654,215––771,780
Mark N. Lampert
–
Dec 22, 2020Conversion+509,410––598,624
Mark N. Lampert
–
Dec 22, 2020Conversion+97,615––113,152
Mark N. Lampert
–
Dec 22, 2020Conversion+1,944––15,537
Israel GP Ltd. OrbiMed
10% owner
Dec 2, 2020Sale−103,200$21.60$2.23M73,650
Global Management LP Logos
10% owner
Oct 30, 2020Sale−12,942$26.64$344.77K187,058
Global Management LP Logos
10% owner
Oct 30, 2020Buy+15,000$26.17$392.55K214,973
Global Management LP Logos
10% owner
Oct 30, 2020Sale−27$27.02$730199,973
Global Management LP Logos
10% owner
Oct 30, 2020Buy+12,942$25.88$334.94K200,000
Global Management LP Logos
10% owner
Oct 30, 2020Buy+9,098$25.55$232.45K224,071
Global Management LP Logos
10% owner
Oct 30, 2020Buy+15,000$26.48$397.20K200,000
Global Management LP Logos
10% owner
Oct 30, 2020Buy+4,000$25.97$103.88K185,000
Global Management LP Logos
10% owner
Oct 30, 2020Buy+31,000$24.53$760.43K181,000
Global Management LP Logos
10% owner
Oct 30, 2020Buy+5,000$24.03$120.15K150,000
Jon Kuwahara
See Remarks
May 21, 2019Sale−1,058$1.91$2.02K5,974
Gregory J. Flesher
Chief Executive Officer, Director
May 21, 2019Sale−2,937$1.91$5.61K156,918
Catherine C. Turkel
President
May 21, 2019Sale−1,914$1.91$3.66K88,662
Jon Kuwahara
See Remarks
May 20, 2019Sale−4,218$1.96$8.27K7,032
Gregory J. Flesher
Chief Executive Officer, Director
May 20, 2019Sale−11,701$1.96$22.93K159,855
Catherine C. Turkel
President
May 20, 2019Sale−7,623$1.96$14.94K90,576
Israel BioFund GP Limited Partnership OrbiMed
Director, 10% owner
May 2, 2019Buy+646,204$3.10$2.00M3,183,314
Erez Chimovits
Director
May 2, 2019Buy+646,204$3.10$2.00M3,183,314
Paul Yook
10% owner
Apr 30, 2019Sale−200$2.70$5401,065,867
Catherine C. Turkel
President
Mar 14, 2019Award+20,000––98,199
Gregory J. Flesher
Chief Executive Officer, Director
Mar 14, 2019Award+25,000––171,556
Catherine C. Turkel
President
Sep 12, 2018Buy+16,632$5.02$83.49K78,199
Catherine C. Turkel
President
Sep 11, 2018Buy+17,048$4.56$77.74K61,567
Catherine C. Turkel
President
Sep 5, 2018Buy+805$3.97$3.20K805
Jon Kuwahara
See Remarks
Mar 13, 2018Award+11,250––11,250
Catherine C. Turkel
President
Mar 13, 2018Award+20,000––44,519
Gregory J. Flesher
Chief Executive Officer, Director
Mar 13, 2018Award+30,700––146,556
Gregory J. Flesher
Chief Executive Officer, Director
May 10, 2017Buy+58,959$9.99$589.00K115,856
Catherine C. Turkel
Chief Development Officer
May 10, 2017Buy+11,111$9.99$111.00K24,519
Christine Ocampo
See Remarks
May 10, 2017Buy+10,010$9.99$100.00K21,590
Israel BioFund GP Limited Partnership OrbiMed
Director, 10% owner
May 9, 2017Award+2,537,110––2,537,110
Stephen Buckley Jr.
Director
Mar 15, 2016Buy+8,000$5.74$45.92K11,000
Jodie Pope Morrison
President and CEO, Director
Jan 8, 2016Option exercise+20,000$1.37$27.40K57,566

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
10.23%
8M shares short
Days to cover
7.5
At 1M shares a day
Change since last report
+4.5%
From 8M shares
Short volume, 20 days
66.1%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Eledon Pharmaceuticals's stock actually held short. Settlement fails (shares not delivered on time) peaked at 66,263 shares on Aug 26, 2026 over the last 90 days.

See a number that looks wrong?